| ICD10 Code - Description | LCD Code | NCD Code |
|---|
|
| B20 - Human immunodeficiency virus [HIV] disease | | 190.23B |
|
| B97.35 - Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere | | 190.23B |
|
| C25 - Malignant neoplasm of pancreas | | 190.23B |
|
| C74 - Malignant neoplasm of adrenal gland | | 190.23B |
|
| C74.0 - Malignant neoplasm of cortex of adrenal gland | | 190.23B |
|
| C74.00 - Malignant neoplasm of cortex of unspecified adrenal gland | | 190.23B |
|
| C74.01 - Malignant neoplasm of cortex of right adrenal gland | | 190.23B |
|
| C74.02 - Malignant neoplasm of cortex of left adrenal gland | | 190.23B |
|
| C74.1 - Malignant neoplasm of medulla of adrenal gland | | 190.23B |
|
| C74.10 - Malignant neoplasm of medulla of unspecified adrenal gland | | 190.23B |
|
| C74.11 - Malignant neoplasm of medulla of right adrenal gland | | 190.23B |
|
| C74.12 - Malignant neoplasm of medulla of left adrenal gland | | 190.23B |
|
| C74.9 - Malignant neoplasm of unspecified part of adrenal gland | | 190.23B |
|
| C74.90 - Malignant neoplasm of unspecified part of unspecified adrenal gland | | 190.23B |
|
| C74.91 - Malignant neoplasm of unspecified part of right adrenal gland | | 190.23B |
|
| C74.92 - Malignant neoplasm of unspecified part of left adrenal gland | | 190.23B |
|
| C79.70 - Secondary malignant neoplasm of unspecified adrenal gland | | 190.23B |
|
| C79.71 - Secondary malignant neoplasm of right adrenal gland | | 190.23B |
|
| C79.72 - Secondary malignant neoplasm of left adrenal gland | | 190.23B |
|
| D13 - Benign neoplasm of other and ill-defined parts of digestive system | | 190.23B |
|
| D13.6 - Benign neoplasm of pancreas | | 190.23B |
|
| D35 - Benign neoplasm of other and unspecified endocrine glands | | 190.23B |
|
| D35.0 - Benign neoplasm of adrenal gland | | 190.23B |
|
| D35.00 - Benign neoplasm of unspecified adrenal gland | | 190.23B |
|
| D3A - Benign neuroendocrine tumors | | 190.23B |
|
| D3A.8 - Other benign neuroendocrine tumors | | 190.23B |
|
| D49 - Neoplasms of unspecified behavior | | 190.23B |
|
| D49.7 - Neoplasm of unspecified behavior of endocrine glands and other parts of nervous system | | 190.23B |
|
| D63 - Anemia in chronic diseases classified elsewhere | | 190.23B |
|
| D63.1 - Anemia in chronic kidney disease | | 190.23B |
|
| D68.9 - Coagulation defect, unspecified | | 190.23B |
|
| E00 - Congenital iodine-deficiency syndrome | | 190.23B |
|
| E00.9 - Congenital iodine-deficiency syndrome, unspecified | | 190.23B |
|
| E01 - Iodine-deficiency related thyroid disorders and allied conditions | | 190.23B |
|
| E01.0 - Iodine-deficiency related diffuse (endemic) goiter | | 190.23B |
|
| E02 - Subclinical iodine-deficiency hypothyroidism | | 190.23B |
|
| E03 - Other hypothyroidism | | 190.23B |
|
| E03.0 - Congenital hypothyroidism with diffuse goiter | | 190.23B |
|
| E03.1 - Congenital hypothyroidism without goiter | | 190.23B |
|
| E03.2 - Hypothyroidism due to medicaments and other exogenous substances | | 190.23B |
|
| E03.3 - Postinfectious hypothyroidism | | 190.23B |
|
| E03.8 - Other specified hypothyroidism | | 190.23B |
|
| E03.9 - Hypothyroidism, unspecified | | 190.23B |
|
| E04 - Other nontoxic goiter | | 190.23B |
|
| E04.2 - Nontoxic multinodular goiter | | 190.23B |
|
| E04.9 - Nontoxic goiter, unspecified | | 190.23B |
|
| E05 - Thyrotoxicosis [hyperthyroidism] | | 190.23B |
|
| E05.0 - Thyrotoxicosis with diffuse goiter | | 190.23B |
|
| E05.1 - Thyrotoxicosis with toxic single thyroid nodule | | 190.23B |
|
| E05.8 - Other thyrotoxicosis | | 190.23B |
|
| E05.9 - Thyrotoxicosis, unspecified | | 190.23B |
|
| E06 - Thyroiditis | | 190.23B |
|
| E06.0 - Acute thyroiditis | | 190.23B |
|
| E06.1 - Subacute thyroiditis | | 190.23B |
|
| E06.2 - Chronic thyroiditis with transient thyrotoxicosis | | 190.23B |
|
| E06.3 - Autoimmune thyroiditis | | 190.23B |
|
| E06.4 - Drug-induced thyroiditis | | 190.23B |
|
| E06.5 - Other chronic thyroiditis | | 190.23B |
|
| E06.9 - Thyroiditis, unspecified | | 190.23B |
|
| E08 - Diabetes mellitus due to underlying condition | | 190.23B |
|
| E08.21 - Diabetes mellitus due to underlying condition with diabetic nephropathy | | 190.23B |
|
| E08.69 - Diabetes mellitus due to underlying condition with other specified complication | | 190.23B |
|
| E08.8 - Diabetes mellitus due to underlying condition with unspecified complications | | 190.23B |
|
| E08.9 - Diabetes mellitus due to underlying condition without complications | | 190.23B |
|
| E09 - Drug or chemical induced diabetes mellitus | | 190.23B |
|
| E10 - Type 1 diabetes mellitus | | 190.23B |
|
| E10.1 - Type 1 diabetes mellitus with ketoacidosis | | 190.23B |
|
| E10.40 - Type 1 diabetes mellitus with diabetic neuropathy, unspecified | | 190.23B |
|
| E10.41 - Type 1 diabetes mellitus with diabetic mononeuropathy | | 190.23B |
|
| E10.42 - Type 1 diabetes mellitus with diabetic polyneuropathy | | 190.23B |
|
| E10.43 - Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy | | 190.23B |
|
| E10.8 - Type 1 diabetes mellitus with unspecified complications | | 190.23B |
|
| E10.9 - Type 1 diabetes mellitus without complications | | 190.23B |
|
| E11 - Type 2 diabetes mellitus | | 190.23B |
|
| E11.69 - Type 2 diabetes mellitus with other specified complication | | 190.23B |
|
| E11.8 - Type 2 diabetes mellitus with unspecified complications | | 190.23B |
|
| E11.9 - Type 2 diabetes mellitus without complications | | 190.23B |
|
| E13 - Other specified diabetes mellitus | | 190.23B |
|
| E13.2 - Other specified diabetes mellitus with kidney complications | | 190.23B |
|
| E13.21 - Other specified diabetes mellitus with diabetic nephropathy | | 190.23B |
|
| E13.22 - Other specified diabetes mellitus with diabetic chronic kidney disease | | 190.23B |
|
| E13.29 - Other specified diabetes mellitus with other diabetic kidney complication | | 190.23B |
|
| E13.9 - Other specified diabetes mellitus without complications | | 190.23B |
|
| E22 - Hyperfunction of pituitary gland | | 190.23B |
|
| E22.0 - Acromegaly and pituitary gigantism | | 190.23B |
|
| E22.8 - Other hyperfunction of pituitary gland | | 190.23B |
|
| E22.9 - Hyperfunction of pituitary gland, unspecified | | 190.23B |
|
| E26 - Hyperaldosteronism | | 190.23B |
|
| E26.1 - Secondary hyperaldosteronism | | 190.23B |
|
| E26.8 - Other hyperaldosteronism | | 190.23B |
|
| E26.9 - Hyperaldosteronism, unspecified | | 190.23B |
|
| E27 - Other disorders of adrenal gland | | 190.23B |
|
| E27.5 - Adrenomedullary hyperfunction | | 190.23B |
|
| E28 - Ovarian dysfunction | | 190.23B |
|
| E28.0 - Estrogen excess | | 190.23B |
|
| E28.2 - Polycystic ovarian syndrome | | 190.23B |
|
| E28.31 - Premature menopause | | 190.23B |
|
| E28.310 - Symptomatic premature menopause | | 190.23B |
|
| E34.4 - Constitutional tall stature | | 190.23B |
|
| E41 - Nutritional marasmus | | 190.23B |
|
| E43 - Unspecified severe protein-calorie malnutrition | | 190.23B |
|
| E44 - Protein-calorie malnutrition of moderate and mild degree | | 190.23B |
|
| E44.0 - Moderate protein-calorie malnutrition | | 190.23B |
|
| E44.1 - Mild protein-calorie malnutrition | | 190.23B |
|
| E45 - Retarded development following protein-calorie malnutrition | | 190.23B |
|
| E46 - Unspecified protein-calorie malnutrition | | 190.23B |
|
| E61 - Deficiency of other nutrient elements | | 190.23B |
|
| E65 - Localized adiposity | | 190.23B |
|
| E66 - Overweight and obesity | | 190.23B |
|
| E66.0 - Obesity due to excess calories | | 190.23B |
|
| E66.09 - Other obesity due to excess calories | | 190.23B |
|
| E66.3 - Overweight | | 190.23B |
|
| E66.8 - Other obesity | | 190.23B |
|
| E66.9 - Obesity, unspecified | | 190.23B |
|
| E70 - Disorders of aromatic amino-acid metabolism | | 190.23B |
|
| E71 - Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism | | 190.23B |
|
| E71.30 - Disorder of fatty-acid metabolism, unspecified | | 190.23B |
|
| E71.31 - Disorders of fatty-acid oxidation | | 190.23B |
|
| E71.310 - Long chain/very long chain acyl CoA dehydrogenase deficiency | | 190.23B |
|
| E71.311 - Medium chain acyl CoA dehydrogenase deficiency | | 190.23B |
|
| E71.312 - Short chain acyl CoA dehydrogenase deficiency | | 190.23B |
|
| E71.5 - Peroxisomal disorders | | 190.23B |
|
| E71.50 - Peroxisomal disorder, unspecified | | 190.23B |
|
| E71.522 - Adrenomyeloneuropathy | | 190.23B |
|
| E72 - Other disorders of amino-acid metabolism | | 190.23B |
|
| E72.11 - Homocystinuria | | 190.23B |
|
| E72.9 - Disorder of amino-acid metabolism, unspecified | | 190.23B |
|
| E74 - Other disorders of carbohydrate metabolism | | 190.23B |
|
| E74.0 - Glycogen storage disease | | 190.23B |
|
| E74.00 - Glycogen storage disease, unspecified | | 190.23B |
|
| E74.01 - von Gierke disease | | 190.23B |
|
| E74.02 - Pompe disease | | 190.23B |
|
| E74.09 - Other glycogen storage disease | | 190.23B |
|
| E75 - Disorders of sphingolipid metabolism and other lipid storage disorders | | 190.23B |
|
| E75.0 - GM2 gangliosidosis | | 190.23B |
|
| E75.00 - GM2 gangliosidosis, unspecified | | 190.23B |
|
| E75.02 - Tay-Sachs disease | | 190.23B |
|
| E75.2 - Other sphingolipidosis | | 190.23B |
|
| E75.21 - Fabry (-Anderson) disease | | 190.23B |
|
| E75.24 - Niemann-Pick disease | | 190.23B |
|
| E75.240 - Niemann-Pick disease type A | | 190.23B |
|
| E75.241 - Niemann-Pick disease type B | | 190.23B |
|
| E75.242 - Niemann-Pick disease type C | | 190.23B |
|
| E75.243 - Niemann-Pick disease type D | | 190.23B |
|
| E75.244 - | | 190.23B |
|
| E75.248 - Other Niemann-Pick disease | | 190.23B |
|
| E75.249 - Niemann-Pick disease, unspecified | | 190.23B |
|
| E75.26 - Sulfatase deficiency | | 190.23B |
|
| E75.29 - Other sphingolipidosis | | 190.23B |
|
| E75.3 - Sphingolipidosis, unspecified | | 190.23B |
|
| E75.5 - Other lipid storage disorders | | 190.23B |
|
| E75.6 - Lipid storage disorder, unspecified | | 190.23B |
|
| E77 - Disorders of glycoprotein metabolism | | 190.23B |
|
| E77.0 - Defects in post-translational modification of lysosomal enzymes | | 190.23B |
|
| E78 - Disorders of lipoprotein metabolism and other lipidemias | | 190.23B |
|
| E78.0 - Pure hypercholesterolemia | | 190.23B |
|
| E78.00 - Pure hypercholesterolemia, unspecified | | 190.23B |
|
| E78.01 - Familial hypercholesterolemia | | 190.23B |
|
| E78.1 - Pure hyperglyceridemia | | 190.23B |
|
| E78.2 - Mixed hyperlipidemia | | 190.23B |
|
| E78.4 - Other hyperlipidemia | | 190.23B |
|
| E78.5 - Hyperlipidemia, unspecified | | 190.23B |
|
| E78.6 - Lipoprotein deficiency | | 190.23B |
|
| E78.8 - Other disorders of lipoprotein metabolism | | 190.23B |
|
| E78.89 - Other lipoprotein metabolism disorders | | 190.23B |
|
| E78.9 - Disorder of lipoprotein metabolism, unspecified | | 190.23B |
|
| E83 - Disorders of mineral metabolism | | 190.23B |
|
| E83.11 - Hemochromatosis | | 190.23B |
|
| E83.110 - Hereditary hemochromatosis | | 190.23B |
|
| E83.111 - Hemochromatosis due to repeated red blood cell transfusions | | 190.23B |
|
| E83.118 - Other hemochromatosis | | 190.23B |
|
| E83.119 - Hemochromatosis, unspecified | | 190.23B |
|
| E85 - Amyloidosis | | 190.23B |
|
| E85.3 - Secondary systemic amyloidosis | | 190.23B |
|
| E85.4 - Organ-limited amyloidosis | | 190.23B |
|
| E85.8 - Other amyloidosis | | 190.23B |
|
| E85.9 - Amyloidosis, unspecified | | 190.23B |
|
| E87 - Other disorders of fluid, electrolyte and acid-base balance | | 190.23B |
|
| E87.1 - Hypo-osmolality and hyponatremia | | 190.23B |
|
| E88 - Other and unspecified metabolic disorders | | 190.23B |
|
| E88.01 - Alpha-1-antitrypsin deficiency | | 190.23B |
|
| E88.81 - Metabolic syndrome | | 190.23B |
|
| E88.9 - Metabolic disorder, unspecified | | 190.23B |
|
| E89 - Postprocedural endocrine and metabolic complications and disorders, not elsewhere classified | | 190.23B |
|
| E89.0 - Postprocedural hypothyroidism | | 190.23B |
|
| F06.4 - Anxiety disorder due to known physiological condition | | 190.23B |
|
| F17 - Nicotine dependence | | 190.23B |
|
| F40 - Phobic anxiety disorders | | 190.23B |
|
| F40.0 - Agoraphobia | | 190.23B |
|
| F40.240 - Claustrophobia | | 190.23B |
|
| F40.8 - Other phobic anxiety disorders | | 190.23B |
|
| F41 - Other anxiety disorders | | 190.23B |
|
| F41.1 - Generalized anxiety disorder | | 190.23B |
|
| F41.3 - Other mixed anxiety disorders | | 190.23B |
|
| F41.9 - Anxiety disorder, unspecified | | 190.23B |
|
| F43 - Reaction to severe stress, and adjustment disorders | | 190.23B |
|
| F43.1 - Post-traumatic stress disorder (PTSD) | | 190.23B |
|
| F43.10 - Post-traumatic stress disorder, unspecified | | 190.23B |
|
| F43.11 - Post-traumatic stress disorder, acute | | 190.23B |
|
| F43.12 - Post-traumatic stress disorder, chronic | | 190.23B |
|
| F98 - Other behavioral and emotional disorders with onset usually occurring in childhood and adolescence | | 190.23B |
|
| G08 - Intracranial and intraspinal phlebitis and thrombophlebitis | | 190.23B |
|
| G11 - Hereditary ataxia | | 190.23B |
|
| G11.1 - Early-onset cerebellar ataxia | | 190.23B |
|
| G11.2 - Late-onset cerebellar ataxia | | 190.23B |
|
| G45 - Transient cerebral ischemic attacks and related syndromes | | 190.23B |
|
| G45.1 - Carotid artery syndrome (hemispheric) | | 190.23B |
|
| G45.3 - Amaurosis fugax | | 190.23B |
|
| G45.9 - Transient cerebral ischemic attack, unspecified | | 190.23B |
|
| G46 - Vascular syndromes of brain in cerebrovascular diseases | | 190.23B |
|
| G46.4 - Cerebellar stroke syndrome | | 190.23B |
|
| G58 - Other mononeuropathies | | 190.23B |
|
| G58.9 - Mononeuropathy, unspecified | | 190.23B |
|
| G60 - Hereditary and idiopathic neuropathy | | 190.23B |
|
| G60.0 - Hereditary motor and sensory neuropathy | | 190.23B |
|
| G60.3 - Idiopathic progressive neuropathy | | 190.23B |
|
| G60.8 - Other hereditary and idiopathic neuropathies | | 190.23B |
|
| G61 - Inflammatory polyneuropathy | | 190.23B |
|
| G61.1 - Serum neuropathy | | 190.23B |
|
| G62 - Other and unspecified polyneuropathies | | 190.23B |
|
| G63 - Polyneuropathy in diseases classified elsewhere | | 190.23B |
|
| G89 - Pain, not elsewhere classified | | 190.23B |
|
| G89.29 - Other chronic pain | | 190.23B |
|
| G89.3 - Neoplasm related pain (acute) (chronic) | | 190.23B |
|
| G89.4 - Chronic pain syndrome | | 190.23B |
|
| G90.0 - Idiopathic peripheral autonomic neuropathy | | 190.23B |
|
| G90.09 - Other idiopathic peripheral autonomic neuropathy | | 190.23B |
|
| G99 - Other disorders of nervous system in diseases classified elsewhere | | 190.23B |
|
| I01 - Rheumatic fever with heart involvement | | 190.23B |
|
| I01.9 - Acute rheumatic heart disease, unspecified | | 190.23B |
|
| I10 - Essential (primary) hypertension | | 190.23B |
|
| I11 - Hypertensive heart disease | | 190.23B |
|
| I11.0 - Hypertensive heart disease with heart failure | | 190.23B |
|
| I11.9 - Hypertensive heart disease without heart failure | | 190.23B |
|
| I12 - Hypertensive chronic kidney disease | | 190.23B |
|
| I13 - Hypertensive heart and chronic kidney disease | | 190.23B |
|
| I15 - Secondary hypertension | | 190.23B |
|
| I15.2 - Hypertension secondary to endocrine disorders | | 190.23B |
|
| I15.8 - Other secondary hypertension | | 190.23B |
|
| I15.9 - Secondary hypertension, unspecified | | 190.23B |
|
| I16 - Hypertensive crisis | | 190.23B |
|
| I20 - Angina pectoris | | 190.23B |
|
| I20.0 - Unstable angina | | 190.23B |
|
| I20.1 - Angina pectoris with documented spasm | | 190.23B |
|
| I20.8 - Other forms of angina pectoris | | 190.23B |
|
| I20.9 - Angina pectoris, unspecified | | 190.23B |
|
| I21 - Acute myocardial infarction | | 190.23B |
|
| I21.0 - ST elevation (STEMI) myocardial infarction of anterior wall | | 190.23B |
|
| I21.1 - ST elevation (STEMI) myocardial infarction of inferior wall | | 190.23B |
|
| I21.2 - ST elevation (STEMI) myocardial infarction of other sites | | 190.23B |
|
| I21.3 - ST elevation (STEMI) myocardial infarction of unspecified site | | 190.23B |
|
| I21.4 - Non-ST elevation (NSTEMI) myocardial infarction | | 190.23B |
|
| I22 - Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction | | 190.23B |
|
| I22.2 - Subsequent non-ST elevation (NSTEMI) myocardial infarction | | 190.23B |
|
| I23 - Certain current complications following ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction (within the 28 day period) | | 190.23B |
|
| I23.7 - Postinfarction angina | | 190.23B |
|
| I23.8 - Other current complications following acute myocardial infarction | | 190.23B |
|
| I24 - Other acute ischemic heart diseases | | 190.23B |
|
| I24.0 - Acute coronary thrombosis not resulting in myocardial infarction | | 190.23B |
|
| I24.8 - Other forms of acute ischemic heart disease | | 190.23B |
|
| I24.89 - | | 190.23B |
|
| I24.9 - Acute ischemic heart disease, unspecified | | 190.23B |
|
| I25 - Chronic ischemic heart disease | | 190.23B |
|
| I25.1 - Atherosclerotic heart disease of native coronary artery | | 190.23B |
|
| I25.10 - Atherosclerotic heart disease of native coronary artery without angina pectoris | | 190.23B |
|
| I25.11 - Atherosclerotic heart disease of native coronary artery with angina pectoris | | 190.23B |
|
| I25.2 - Old myocardial infarction | | 190.23B |
|
| I25.3 - Aneurysm of heart | | 190.23B |
|
| I25.41 - Coronary artery aneurysm | | 190.23B |
|
| I25.42 - Coronary artery dissection | | 190.23B |
|
| I25.5 - Ischemic cardiomyopathy | | 190.23B |
|
| I25.7 - Atherosclerosis of coronary artery bypass graft(s) and coronary artery of transplanted heart with angina pectoris | | 190.23B |
|
| I25.8 - Other forms of chronic ischemic heart disease | | 190.23B |
|
| I25.9 - Chronic ischemic heart disease, unspecified | | 190.23B |
|
| I34 - Nonrheumatic mitral valve disorders | | 190.23B |
|
| I35 - Nonrheumatic aortic valve disorders | | 190.23B |
|
| I41 - Myocarditis in diseases classified elsewhere | | 190.23B |
|
| I42 - Cardiomyopathy | | 190.23B |
|
| I42.0 - Dilated cardiomyopathy | | 190.23B |
|
| I42.8 - Other cardiomyopathies | | 190.23B |
|
| I42.9 - Cardiomyopathy, unspecified | | 190.23B |
|
| I43 - Cardiomyopathy in diseases classified elsewhere | | 190.23B |
|
| I48 - Atrial fibrillation and flutter | | 190.23B |
|
| I48.0 - Paroxysmal atrial fibrillation | | 190.23B |
|
| I48.1 - Persistent atrial fibrillation | | 190.23B |
|
| I48.2 - Chronic atrial fibrillation | | 190.23B |
|
| I48.9 - Unspecified atrial fibrillation and atrial flutter | | 190.23B |
|
| I48.91 - Unspecified atrial fibrillation | | 190.23B |
|
| I49 - Other cardiac arrhythmias | | 190.23B |
|
| I49.0 - Ventricular fibrillation and flutter | | 190.23B |
|
| I49.8 - Other specified cardiac arrhythmias | | 190.23B |
|
| I49.9 - Cardiac arrhythmia, unspecified | | 190.23B |
|
| I50 - Heart failure | | 190.23B |
|
| I50.20 - Unspecified systolic (congestive) heart failure | | 190.23B |
|
| I50.21 - Acute systolic (congestive) heart failure | | 190.23B |
|
| I50.22 - Chronic systolic (congestive) heart failure | | 190.23B |
|
| I50.23 - Acute on chronic systolic (congestive) heart failure | | 190.23B |
|
| I50.30 - Unspecified diastolic (congestive) heart failure | | 190.23B |
|
| I50.31 - Acute diastolic (congestive) heart failure | | 190.23B |
|
| I50.32 - Chronic diastolic (congestive) heart failure | | 190.23B |
|
| I50.33 - Acute on chronic diastolic (congestive) heart failure | | 190.23B |
|
| I50.40 - Unspecified combined systolic (congestive) and diastolic (congestive) heart failure | | 190.23B |
|
| I50.41 - Acute combined systolic (congestive) and diastolic (congestive) heart failure | | 190.23B |
|
| I50.42 - Chronic combined systolic (congestive) and diastolic (congestive) heart failure | | 190.23B |
|
| I50.43 - Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure | | 190.23B |
|
| I50.9 - Heart failure, unspecified | | 190.23B |
|
| I51 - Complications and ill-defined descriptions of heart disease | | 190.23B |
|
| I51.7 - Cardiomegaly | | 190.23B |
|
| I51.9 - Heart disease, unspecified | | 190.23B |
|
| I52 - Other heart disorders in diseases classified elsewhere | | 190.23B |
|
| I5A - | | 190.23B |
|
| I61 - Nontraumatic intracerebral hemorrhage | | 190.23B |
|
| I61.9 - Nontraumatic intracerebral hemorrhage, unspecified | | 190.23B |
|
| I62 - Other and unspecified nontraumatic intracranial hemorrhage | | 190.23B |
|
| I62.0 - Nontraumatic subdural hemorrhage | | 190.23B |
|
| I63 - Cerebral infarction | | 190.23B |
|
| I63.0 - Cerebral infarction due to thrombosis of precerebral arteries | | 190.23B |
|
| I63.00 - Cerebral infarction due to thrombosis of unspecified precerebral artery | | 190.23B |
|
| I63.8 - Other cerebral infarction | | 190.23B |
|
| I63.9 - Cerebral infarction, unspecified | | 190.23B |
|
| I65 - Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction | | 190.23B |
|
| I65.21 - Occlusion and stenosis of right carotid artery | | 190.23B |
|
| I65.22 - Occlusion and stenosis of left carotid artery | | 190.23B |
|
| I65.23 - Occlusion and stenosis of bilateral carotid arteries | | 190.23B |
|
| I65.29 - Occlusion and stenosis of unspecified carotid artery | | 190.23B |
|
| I66 - Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction | | 190.23B |
|
| I66.3 - Occlusion and stenosis of cerebellar arteries | | 190.23B |
|
| I66.9 - Occlusion and stenosis of unspecified cerebral artery | | 190.23B |
|
| I67 - Other cerebrovascular diseases | | 190.23B |
|
| I67.1 - Cerebral aneurysm, nonruptured | | 190.23B |
|
| I67.2 - Cerebral atherosclerosis | | 190.23B |
|
| I67.82 - Cerebral ischemia | | 190.23B |
|
| I68.0 - Cerebral amyloid angiopathy | | 190.23B |
|
| I69 - Sequelae of cerebrovascular disease | | 190.23B |
|
| I69.0 - Sequelae of nontraumatic subarachnoid hemorrhage | | 190.23B |
|
| I69.00 - Unspecified sequelae of nontraumatic subarachnoid hemorrhage | | 190.23B |
|
| I69.093 - Ataxia following nontraumatic subarachnoid hemorrhage | | 190.23B |
|
| I70 - Atherosclerosis | | 190.23B |
|
| I70.0 - Atherosclerosis of aorta | | 190.23B |
|
| I70.91 - Generalized atherosclerosis | | 190.23B |
|
| I71 - Aortic aneurysm and dissection | | 190.23B |
|
| I71.02 - Dissection of abdominal aorta | | 190.23B |
|
| I71.13 - | | 190.23B |
|
| I71.23 - | | 190.23B |
|
| I71.3 - Abdominal aortic aneurysm, ruptured | | 190.23B |
|
| I71.30 - | | 190.23B |
|
| I71.31 - | | 190.23B |
|
| I71.32 - | | 190.23B |
|
| I71.33 - | | 190.23B |
|
| I71.4 - Abdominal aortic aneurysm, without rupture | | 190.23B |
|
| I71.40 - | | 190.23B |
|
| I72 - Other aneurysm | | 190.23B |
|
| I72.0 - Aneurysm of carotid artery | | 190.23B |
|
| I72.9 - Aneurysm of unspecified site | | 190.23B |
|
| I77 - Other disorders of arteries and arterioles | | 190.23B |
|
| I77.6 - Arteritis, unspecified | | 190.23B |
|
| I87 - Other disorders of veins | | 190.23B |
|
| I87.39 - Chronic venous hypertension (idiopathic) with other complications | | 190.23B |
|
| I95 - Hypotension | | 190.23B |
|
| I95.0 - Idiopathic hypotension | | 190.23B |
|
| I99 - Other and unspecified disorders of circulatory system | | 190.23B |
|
| K52 - Other and unspecified noninfective gastroenteritis and colitis | | 190.23B |
|
| K70 - Alcoholic liver disease | | 190.23B |
|
| K70.0 - Alcoholic fatty liver | | 190.23B |
|
| K70.1 - Alcoholic hepatitis | | 190.23B |
|
| K70.3 - Alcoholic cirrhosis of liver | | 190.23B |
|
| K70.30 - Alcoholic cirrhosis of liver without ascites | | 190.23B |
|
| K70.31 - Alcoholic cirrhosis of liver with ascites | | 190.23B |
|
| K70.4 - Alcoholic hepatic failure | | 190.23B |
|
| K71 - Toxic liver disease | | 190.23B |
|
| K71.3 - Toxic liver disease with chronic persistent hepatitis | | 190.23B |
|
| K71.7 - Toxic liver disease with fibrosis and cirrhosis of liver | | 190.23B |
|
| K72 - Hepatic failure, not elsewhere classified | | 190.23B |
|
| K72.00 - Acute and subacute hepatic failure without coma | | 190.23B |
|
| K72.01 - Acute and subacute hepatic failure with coma | | 190.23B |
|
| K72.11 - Chronic hepatic failure with coma | | 190.23B |
|
| K72.90 - Hepatic failure, unspecified without coma | | 190.23B |
|
| K72.91 - Hepatic failure, unspecified with coma | | 190.23B |
|
| K73 - Chronic hepatitis, not elsewhere classified | | 190.23B |
|
| K74 - Fibrosis and cirrhosis of liver | | 190.23B |
|
| K74.0 - Hepatic fibrosis | | 190.23B |
|
| K74.00 - Hepatic fibrosis, unspecified | | 190.23B |
|
| K74.01 - Hepatic fibrosis, early fibrosis | | 190.23B |
|
| K74.02 - Hepatic fibrosis, advanced fibrosis | | 190.23B |
|
| K74.2 - Hepatic fibrosis with hepatic sclerosis | | 190.23B |
|
| K74.3 - Primary biliary cirrhosis | | 190.23B |
|
| K74.4 - Secondary biliary cirrhosis | | 190.23B |
|
| K74.5 - Biliary cirrhosis, unspecified | | 190.23B |
|
| K74.6 - Other and unspecified cirrhosis of liver | | 190.23B |
|
| K74.60 - Unspecified cirrhosis of liver | | 190.23B |
|
| K74.69 - Other cirrhosis of liver | | 190.23B |
|
| K75 - Other inflammatory liver diseases | | 190.23B |
|
| K75.81 - Nonalcoholic steatohepatitis (NASH) | | 190.23B |
|
| K76 - Other diseases of liver | | 190.23B |
|
| K76.0 - Fatty (change of) liver, not elsewhere classified | | 190.23B |
|
| K76.1 - Chronic passive congestion of liver | | 190.23B |
|
| K76.2 - Central hemorrhagic necrosis of liver | | 190.23B |
|
| K76.8 - Other specified diseases of liver | | 190.23B |
|
| K76.89 - Other specified diseases of liver | | 190.23B |
|
| K76.9 - Liver disease, unspecified | | 190.23B |
|
| K80 - Cholelithiasis | | 190.23B |
|
| K80.0 - Calculus of gallbladder with acute cholecystitis | | 190.23B |
|
| K83 - Other diseases of biliary tract | | 190.23B |
|
| K83.1 - Obstruction of bile duct | | 190.23B |
|
| K85 - Acute pancreatitis | | 190.23B |
|
| K85.0 - Idiopathic acute pancreatitis | | 190.23B |
|
| K85.1 - Biliary acute pancreatitis | | 190.23B |
|
| K85.2 - Alcohol induced acute pancreatitis | | 190.23B |
|
| K85.20 - Alcohol induced acute pancreatitis without necrosis or infection | | 190.23B |
|
| K85.3 - Drug induced acute pancreatitis | | 190.23B |
|
| K85.8 - Other acute pancreatitis | | 190.23B |
|
| K85.9 - Acute pancreatitis, unspecified | | 190.23B |
|
| K86 - Other diseases of pancreas | | 190.23B |
|
| K86.0 - Alcohol-induced chronic pancreatitis | | 190.23B |
|
| K86.1 - Other chronic pancreatitis | | 190.23B |
|
| K86.8 - Other specified diseases of pancreas | | 190.23B |
|
| K86.9 - Disease of pancreas, unspecified | | 190.23B |
|
| K90 - Intestinal malabsorption | | 190.23B |
|
| K90.8 - Other intestinal malabsorption | | 190.23B |
|
| K90.89 - Other intestinal malabsorption | | 190.23B |
|
| K90.9 - Intestinal malabsorption, unspecified | | 190.23B |
|
| K91.1 - Postgastric surgery syndromes | | 190.23B |
|
| K91.2 - Postsurgical malabsorption, not elsewhere classified | | 190.23B |
|
| L12 - Pemphigoid | | 190.23B |
|
| L12.3 - Acquired epidermolysis bullosa | | 190.23B |
|
| L12.30 - Acquired epidermolysis bullosa, unspecified | | 190.23B |
|
| L12.9 - Pemphigoid, unspecified | | 190.23B |
|
| L83 - Acanthosis nigricans | | 190.23B |
|
| M05.5 - Rheumatoid polyneuropathy with rheumatoid arthritis | | 190.23B |
|
| M30 - Polyarteritis nodosa and related conditions | | 190.23B |
|
| M30.0 - Polyarteritis nodosa | | 190.23B |
|
| M30.1 - Polyarteritis with lung involvement [Churg-Strauss] | | 190.23B |
|
| M30.2 - Juvenile polyarteritis | | 190.23B |
|
| M30.3 - Mucocutaneous lymph node syndrome [Kawasaki] | | 190.23B |
|
| M30.8 - Other conditions related to polyarteritis nodosa | | 190.23B |
|
| M32 - Systemic lupus erythematosus (SLE) | | 190.23B |
|
| M32.1 - Systemic lupus erythematosus with organ or system involvement | | 190.23B |
|
| M32.10 - Systemic lupus erythematosus, organ or system involvement unspecified | | 190.23B |
|
| M33 - Dermatopolymyositis | | 190.23B |
|
| M33.0 - Juvenile dermatomyositis | | 190.23B |
|
| M33.1 - Other dermatomyositis | | 190.23B |
|
| M33.9 - Dermatopolymyositis, unspecified | | 190.23B |
|
| N00 - Acute nephritic syndrome | | 190.23B |
|
| N00.3 - Acute nephritic syndrome with diffuse mesangial proliferative glomerulonephritis | | 190.23B |
|
| N00.9 - Acute nephritic syndrome with unspecified morphologic changes | | 190.23B |
|
| N01 - Rapidly progressive nephritic syndrome | | 190.23B |
|
| N01.2 - Rapidly progressive nephritic syndrome with diffuse membranous glomerulonephritis | | 190.23B |
|
| N02.2 - Recurrent and persistent hematuria with diffuse membranous glomerulonephritis | | 190.23B |
|
| N02.A - Recurrent and persistent hematuria with C3 glomerulonephritis | | 190.23B |
|
| N02.B3 - | | 190.23B |
|
| N03 - Chronic nephritic syndrome | | 190.23B |
|
| N03.0 - Chronic nephritic syndrome with minor glomerular abnormality | | 190.23B |
|
| N03.2 - Chronic nephritic syndrome with diffuse membranous glomerulonephritis | | 190.23B |
|
| N03.3 - Chronic nephritic syndrome with diffuse mesangial proliferative glomerulonephritis | | 190.23B |
|
| N03.4 - Chronic nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis | | 190.23B |
|
| N03.5 - Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis | | 190.23B |
|
| N03.7 - Chronic nephritic syndrome with diffuse crescentic glomerulonephritis | | 190.23B |
|
| N03.9 - Chronic nephritic syndrome with unspecified morphologic changes | | 190.23B |
|
| N03.A - Chronic nephritic syndrome with C3 glomerulonephritis | | 190.23B |
|
| N04 - Nephrotic syndrome | | 190.23B |
|
| N04.2 - Nephrotic syndrome with diffuse membranous glomerulonephritis | | 190.23B |
|
| N04.3 - Nephrotic syndrome with diffuse mesangial proliferative glomerulonephritis | | 190.23B |
|
| N04.8 - Nephrotic syndrome with other morphologic changes | | 190.23B |
|
| N04.9 - Nephrotic syndrome with unspecified morphologic changes | | 190.23B |
|
| N05 - Unspecified nephritic syndrome | | 190.23B |
|
| N05.0 - Unspecified nephritic syndrome with minor glomerular abnormality | | 190.23B |
|
| N05.2 - Unspecified nephritic syndrome with diffuse membranous glomerulonephritis | | 190.23B |
|
| N05.5 - Unspecified nephritic syndrome with diffuse mesangiocapillary glomerulonephritis | | 190.23B |
|
| N08 - Glomerular disorders in diseases classified elsewhere | | 190.23B |
|
| N10 - Acute pyelonephritis | | 190.23B |
|
| N11.8 - Other chronic tubulo-interstitial nephritis | | 190.23B |
|
| N12 - Tubulo-interstitial nephritis, not specified as acute or chronic | | 190.23B |
|
| N13 - Obstructive and reflux uropathy | | 190.23B |
|
| N18 - Chronic kidney disease (CKD) | | 190.23B |
|
| N18.9 - Chronic kidney disease, unspecified | | 190.23B |
|
| N23 - Unspecified renal colic | | 190.23B |
|
| N26 - Unspecified contracted kidney | | 190.23B |
|
| N26.9 - Renal sclerosis, unspecified | | 190.23B |
|
| N28 - Other disorders of kidney and ureter, not elsewhere classified | | 190.23B |
|
| N28.1 - Cyst of kidney, acquired | | 190.23B |
|
| N83.20 - Unspecified ovarian cysts | | 190.23B |
|
| N95 - Menopausal and other perimenopausal disorders | | 190.23B |
|
| N95.0 - Postmenopausal bleeding | | 190.23B |
|
| N95.1 - Menopausal and female climacteric states | | 190.23B |
|
| N95.2 - Postmenopausal atrophic vaginitis | | 190.23B |
|
| N95.8 - Other specified menopausal and perimenopausal disorders | | 190.23B |
|
| N95.9 - Unspecified menopausal and perimenopausal disorder | | 190.23B |
|
| N97 - Female infertility | | 190.23B |
|
| N97.9 - Female infertility, unspecified | | 190.23B |
|
| N98.3 - Complications of attempted introduction of embryo in embryo transfer | | 190.23B |
|
| O09 - Supervision of high risk pregnancy | | 190.23B |
|
| O09.0 - Supervision of pregnancy with history of infertility | | 190.23B |
|
| O09.3 - Supervision of pregnancy with insufficient antenatal care | | 190.23B |
|
| O16 - Unspecified maternal hypertension | | 190.23B |
|
| O23.9 - Unspecified genitourinary tract infection in pregnancy | | 190.23B |
|
| O23.90 - Unspecified genitourinary tract infection in pregnancy, unspecified trimester | | 190.23B |
|
| O23.91 - Unspecified genitourinary tract infection in pregnancy, first trimester | | 190.23B |
|
| O23.92 - Unspecified genitourinary tract infection in pregnancy, second trimester | | 190.23B |
|
| O23.93 - Unspecified genitourinary tract infection in pregnancy, third trimester | | 190.23B |
|
| O24 - Diabetes mellitus in pregnancy, childbirth, and the puerperium | | 190.23B |
|
| O24.02 - Pre-existing type 1 diabetes mellitus, in childbirth | | 190.23B |
|
| O24.1 - Pre-existing type 2 diabetes mellitus, in pregnancy, childbirth and the puerperium | | 190.23B |
|
| O24.4 - Gestational diabetes mellitus | | 190.23B |
|
| O24.41 - Gestational diabetes mellitus in pregnancy | | 190.23B |
|
| O26 - Maternal care for other conditions predominantly related to pregnancy | | 190.23B |
|
| O28 - Abnormal findings on antenatal screening of mother | | 190.23B |
|
| O28.9 - Unspecified abnormal findings on antenatal screening of mother | | 190.23B |
|
| O34.0 - Maternal care for congenital malformation of uterus | | 190.23B |
|
| O35 - Maternal care for known or suspected fetal abnormality and damage | | 190.23B |
|
| O35.0 - Maternal care for (suspected) central nervous system malformation in fetus | | 190.23B |
|
| O35.02 - | | 190.23B |
|
| O35.04 - | | 190.23B |
|
| O35.06 - | | 190.23B |
|
| O35.08 - | | 190.23B |
|
| O36.01 - Maternal care for anti-D [Rh] antibodies | | 190.23B |
|
| O86.2 - Urinary tract infection following delivery | | 190.23B |
|
| O90 - Complications of the puerperium, not elsewhere classified | | 190.23B |
|
| O90.5 - Postpartum thyroiditis | | 190.23B |
|
| O98 - Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium | | 190.23B |
|
| O98.71 - Human immunodeficiency virus [HIV] disease complicating pregnancy | | 190.23B |
|
| O99.01 - Anemia complicating pregnancy | | 190.23B |
|
| O99.280 - Endocrine, nutritional and metabolic diseases complicating pregnancy, unspecified trimester | | 190.23B |
|
| O99.810 - Abnormal glucose complicating pregnancy | | 190.23B |
|
| O99.814 - Abnormal glucose complicating childbirth | | 190.23B |
|
| O99.830 - Other infection carrier state complicating pregnancy | | 190.23B |
|
| P04 - Newborn affected by noxious substances transmitted via placenta or breast milk | | 190.23B |
|
| P04.2 - Newborn affected by maternal use of tobacco | | 190.23B |
|
| P78.81 - Congenital cirrhosis (of liver) | | 190.23B |
|
| Q04 - Other congenital malformations of brain | | 190.23B |
|
| Q06 - Other congenital malformations of spinal cord | | 190.23B |
|
| Q07 - Other congenital malformations of nervous system | | 190.23B |
|
| Q10 - Congenital malformations of eyelid, lacrimal apparatus and orbit | | 190.23B |
|
| Q13 - Congenital malformations of anterior segment of eye | | 190.23B |
|
| Q14 - Congenital malformations of posterior segment of eye | | 190.23B |
|
| Q15 - Other congenital malformations of eye | | 190.23B |
|
| Q16 - Congenital malformations of ear causing impairment of hearing | | 190.23B |
|
| Q17 - Other congenital malformations of ear | | 190.23B |
|
| Q18 - Other congenital malformations of face and neck | | 190.23B |
|
| Q20 - Congenital malformations of cardiac chambers and connections | | 190.23B |
|
| Q21 - Congenital malformations of cardiac septa | | 190.23B |
|
| Q22 - Congenital malformations of pulmonary and tricuspid valves | | 190.23B |
|
| Q23 - Congenital malformations of aortic and mitral valves | | 190.23B |
|
| Q24 - Other congenital malformations of heart | | 190.23B |
|
| Q25 - Congenital malformations of great arteries | | 190.23B |
|
| Q26 - Congenital malformations of great veins | | 190.23B |
|
| Q27 - Other congenital malformations of peripheral vascular system | | 190.23B |
|
| Q28 - Other congenital malformations of circulatory system | | 190.23B |
|
| Q30 - Congenital malformations of nose | | 190.23B |
|
| Q31 - Congenital malformations of larynx | | 190.23B |
|
| Q32 - Congenital malformations of trachea and bronchus | | 190.23B |
|
| Q33 - Congenital malformations of lung | | 190.23B |
|
| Q34 - Other congenital malformations of respiratory system | | 190.23B |
|
| Q38 - Other congenital malformations of tongue, mouth and pharynx | | 190.23B |
|
| Q39 - Congenital malformations of esophagus | | 190.23B |
|
| Q40 - Other congenital malformations of upper alimentary tract | | 190.23B |
|
| Q43 - Other congenital malformations of intestine | | 190.23B |
|
| Q44 - Congenital malformations of gallbladder, bile ducts and liver | | 190.23B |
|
| Q45 - Other congenital malformations of digestive system | | 190.23B |
|
| Q50 - Congenital malformations of ovaries, fallopian tubes and broad ligaments | | 190.23B |
|
| Q51 - Congenital malformations of uterus and cervix | | 190.23B |
|
| Q52 - Other congenital malformations of female genitalia | | 190.23B |
|
| Q55 - Other congenital malformations of male genital organs | | 190.23B |
|
| Q61 - Cystic kidney disease | | 190.23B |
|
| Q61.02 - Congenital multiple renal cysts | | 190.23B |
|
| Q61.3 - Polycystic kidney, unspecified | | 190.23B |
|
| Q61.9 - Cystic kidney disease, unspecified | | 190.23B |
|
| Q62 - Congenital obstructive defects of renal pelvis and congenital malformations of ureter | | 190.23B |
|
| Q63 - Other congenital malformations of kidney | | 190.23B |
|
| Q64 - Other congenital malformations of urinary system | | 190.23B |
|
| Q74 - Other congenital malformations of limb(s) | | 190.23B |
|
| Q75 - Other congenital malformations of skull and face bones | | 190.23B |
|
| Q76 - Congenital malformations of spine and bony thorax | | 190.23B |
|
| Q79 - Congenital malformations of musculoskeletal system, not elsewhere classified | | 190.23B |
|
| Q81 - Epidermolysis bullosa | | 190.23B |
|
| Q81.9 - Epidermolysis bullosa, unspecified | | 190.23B |
|
| Q82 - Other congenital malformations of skin | | 190.23B |
|
| Q82.8 - Other specified congenital malformations of skin | | 190.23B |
|
| Q82.9 - Congenital malformation of skin, unspecified | | 190.23B |
|
| Q83 - Congenital malformations of breast | | 190.23B |
|
| Q84 - Other congenital malformations of integument | | 190.23B |
|
| Q86 - Congenital malformation syndromes due to known exogenous causes, not elsewhere classified | | 190.23B |
|
| Q87 - Other specified congenital malformation syndromes affecting multiple systems | | 190.23B |
|
| Q87.1 - Congenital malformation syndromes predominantly associated with short stature | | 190.23B |
|
| Q89 - Other congenital malformations, not elsewhere classified | | 190.23B |
|
| Q89.7 - Multiple congenital malformations, not elsewhere classified | | 190.23B |
|
| Q89.8 - Other specified congenital malformations | | 190.23B |
|
| Q89.9 - Congenital malformation, unspecified | | 190.23B |
|
| Q95 - Balanced rearrangements and structural markers, not elsewhere classified | | 190.23B |
|
| Q95.1 - Chromosome inversion in normal individual | | 190.23B |
|
| R00 - Abnormalities of heart beat | | 190.23B |
|
| R01 - Cardiac murmurs and other cardiac sounds | | 190.23B |
|
| R03 - Abnormal blood-pressure reading, without diagnosis | | 190.23B |
|
| R42 - Dizziness and giddiness | | 190.23B |
|
| R43.0 - Anosmia | | 190.23B |
|
| R54 - Age-related physical debility | | 190.23B |
|
| R73 - Elevated blood glucose level | | 190.23B |
|
| R74 - Abnormal serum enzyme levels | | 190.23B |
|
| R74.0 - Nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [LDH] | | 190.23B |
|
| R74.01 - Elevation of levels of liver transaminase levels | | 190.23B |
|
| R75 - Inconclusive laboratory evidence of human immunodeficiency virus [HIV] | | 190.23B |
|
| R77 - Other abnormalities of plasma proteins | | 190.23B |
|
| R79 - Other abnormal findings of blood chemistry | | 190.23B |
|
| R79.1 - Abnormal coagulation profile | | 190.23B |
|
| R94 - Abnormal results of function studies | | 190.23B |
|
| R94.31 - Abnormal electrocardiogram [ECG] [EKG] | | 190.23B |
|
| R94.39 - Abnormal result of other cardiovascular function study | | 190.23B |
|
| R94.4 - Abnormal results of kidney function studies | | 190.23B |
|
| R94.5 - Abnormal results of liver function studies | | 190.23B |
|
| R94.6 - Abnormal results of thyroid function studies | | 190.23B |
|
| T45.615 - Adverse effect of thrombolytic drugs | | 190.23B |
|
| T45.615A - Adverse effect of thrombolytic drugs, initial encounter | | 190.23B |
|
| T45.615D - Adverse effect of thrombolytic drugs, subsequent encounter | | 190.23B |
|
| T45.615S - Adverse effect of thrombolytic drugs, sequela | | 190.23B |
|
| T82 - Complications of cardiac and vascular prosthetic devices, implants and grafts | | 190.23B |
|
| T82.855 - Stenosis of coronary artery stent | | 190.23B |
|
| T82.855A - Stenosis of coronary artery stent, initial encounter | | 190.23B |
|
| T82.855S - Stenosis of coronary artery stent, sequela | | 190.23B |
|
| T86 - Complications of transplanted organs and tissue | | 190.23B |
|
| T86.1 - Complications of kidney transplant | | 190.23B |
|
| T86.10 - Unspecified complication of kidney transplant | | 190.23B |
|
| T86.11 - Kidney transplant rejection | | 190.23B |
|
| T86.12 - Kidney transplant failure | | 190.23B |
|
| T86.19 - Other complication of kidney transplant | | 190.23B |
|
| T86.2 - Complications of heart transplant | | 190.23B |
|
| T86.21 - Heart transplant rejection | | 190.23B |
|
| T86.22 - Heart transplant failure | | 190.23B |
|
| T86.29 - Other complications of heart transplant | | 190.23B |
|
| T86.4 - Complications of liver transplant | | 190.23B |
|
| T86.40 - Unspecified complication of liver transplant | | 190.23B |
|
| T86.41 - Liver transplant rejection | | 190.23B |
|
| T86.42 - Liver transplant failure | | 190.23B |
|
| T86.43 - Liver transplant infection | | 190.23B |
|
| T86.49 - Other complications of liver transplant | | 190.23B |
|
| Z00 - Encounter for general examination without complaint, suspected or reported diagnosis | | 190.23B |
|
| Z00.0 - Encounter for general adult medical examination | | 190.23B |
|
| Z00.00 - Encounter for general adult medical examination without abnormal findings | | 190.23B |
|
| Z00.01 - Encounter for general adult medical examination with abnormal findings | | 190.23B |
|
| Z00.8 - Encounter for other general examination | | 190.23B |
|
| Z01.41 - Encounter for routine gynecological examination | | 190.23B |
|
| Z01.411 - Encounter for gynecological examination (general) (routine) with abnormal findings | | 190.23B |
|
| Z01.810 - Encounter for preprocedural cardiovascular examination | | 190.23B |
|
| Z01.83 - Encounter for blood typing | | 190.23B |
|
| Z01.84 - Encounter for antibody response examination | | 190.23B |
|
| Z02 - Encounter for administrative examination | | 190.23B |
|
| Z04 - Encounter for examination and observation for other reasons | | 190.23B |
|
| Z11.3 - Encounter for screening for infections with a predominantly sexual mode of transmission | | 190.23B |
|
| Z11.4 - Encounter for screening for human immunodeficiency virus [HIV] | | 190.23B |
|
| Z11.5 - Encounter for screening for other viral diseases | | 190.23B |
|
| Z11.51 - Encounter for screening for human papillomavirus (HPV) | | 190.23B |
|
| Z12.10 - Encounter for screening for malignant neoplasm of intestinal tract, unspecified | | 190.23B |
|
| Z13 - Encounter for screening for other diseases and disorders | | 190.23B |
|
| Z13.1 - Encounter for screening for diabetes mellitus | | 190.23B |
|
| Z13.21 - Encounter for screening for nutritional disorder | | 190.23B |
|
| Z13.22 - Encounter for screening for metabolic disorder | | 190.23B |
|
| Z13.220 - Encounter for screening for lipoid disorders | | 190.23B |
|
| Z13.228 - Encounter for screening for other metabolic disorders | | 190.23B |
|
| Z13.40 - Encounter for screening for unspecified developmental delays | | 190.23B |
|
| Z13.41 - Encounter for autism screening | | 190.23B |
|
| Z13.42 - Encounter for screening for global developmental delays (milestones) | | 190.23B |
|
| Z13.49 - Encounter for screening for other developmental delays | | 190.23B |
|
| Z13.5 - Encounter for screening for eye and ear disorders | | 190.23B |
|
| Z13.6 - Encounter for screening for cardiovascular disorders | | 190.23B |
|
| Z13.7 - Encounter for screening for genetic and chromosomal anomalies | | 190.23B |
|
| Z13.71 - Encounter for nonprocreative screening for genetic disease carrier status | | 190.23B |
|
| Z14 - Genetic carrier | | 190.23B |
|
| Z16 - Resistance to antimicrobial drugs | | 190.23B |
|
| Z16.33 - Resistance to antiviral drug(s) | | 190.23B |
|
| Z20 - Contact with and (suspected) exposure to communicable diseases | | 190.23B |
|
| Z20.6 - Contact with and (suspected) exposure to human immunodeficiency virus [HIV] | | 190.23B |
|
| Z21 - Asymptomatic human immunodeficiency virus [HIV] infection status | | 190.23B |
|
| Z30.014 - Encounter for initial prescription of intrauterine contraceptive device | | 190.23B |
|
| Z30.8 - Encounter for other contraceptive management | | 190.23B |
|
| Z31.430 - Encounter of female for testing for genetic disease carrier status for procreative management | | 190.23B |
|
| Z31.440 - Encounter of male for testing for genetic disease carrier status for procreative management | | 190.23B |
|
| Z31.5 - Encounter for procreative genetic counseling | | 190.23B |
|
| Z31.81 - Encounter for male factor infertility in female patient | | 190.23B |
|
| Z32.0 - Encounter for pregnancy test | | 190.23B |
|
| Z33 - Pregnant state | | 190.23B |
|
| Z34 - Encounter for supervision of normal pregnancy | | 190.23B |
|
| Z34.0 - Encounter for supervision of normal first pregnancy | | 190.23B |
|
| Z34.00 - Encounter for supervision of normal first pregnancy, unspecified trimester | | 190.23B |
|
| Z34.8 - Encounter for supervision of other normal pregnancy | | 190.23B |
|
| Z34.9 - Encounter for supervision of normal pregnancy, unspecified | | 190.23B |
|
| Z34.90 - Encounter for supervision of normal pregnancy, unspecified, unspecified trimester | | 190.23B |
|
| Z36 - Encounter for antenatal screening of mother | | 190.23B |
|
| Z36.0 - Encounter for antenatal screening for chromosomal anomalies | | 190.23B |
|
| Z36.4 - Encounter for antenatal screening for fetal growth retardation | | 190.23B |
|
| Z36.8 - Encounter for other antenatal screening | | 190.23B |
|
| Z48.21 - Encounter for aftercare following heart transplant | | 190.23B |
|
| Z48.23 - Encounter for aftercare following liver transplant | | 190.23B |
|
| Z51.1 - Encounter for antineoplastic chemotherapy and immunotherapy | | 190.23B |
|
| Z67 - Blood type | | 190.23B |
|
| Z68 - Body mass index [BMI] | | 190.23B |
|
| Z71.7 - Human immunodeficiency virus [HIV] counseling | | 190.23B |
|
| Z72 - Problems related to lifestyle | | 190.23B |
|
| Z72.0 - Tobacco use | | 190.23B |
|
| Z77 - Other contact with and (suspected) exposures hazardous to health | | 190.23B |
|
| Z77.120 - Contact with and (suspected) exposure to mold (toxic) | | 190.23B |
|
| Z78.0 - Asymptomatic menopausal state | | 190.23B |
|
| Z79 - Long term (current) drug therapy | | 190.23B |
|
| Z79.0 - Long term (current) use of anticoagulants and antithrombotics/antiplatelets | | 190.23B |
|
| Z79.01 - Long term (current) use of anticoagulants | | 190.23B |
|
| Z79.02 - Long term (current) use of antithrombotics/antiplatelets | | 190.23B |
|
| Z79.1 - Long term (current) use of non-steroidal anti-inflammatories (NSAID) | | 190.23B |
|
| Z79.4 - Long term (current) use of insulin | | 190.23B |
|
| Z79.84 - Long term (current) use of oral hypoglycemic drugs | | 190.23B |
|
| Z79.89 - Other long term (current) drug therapy | | 190.23B |
|
| Z79.899 - Other long term (current) drug therapy | | 190.23B |
|
| Z81.2 - Family history of tobacco abuse and dependence | | 190.23B |
|
| Z82.3 - Family history of stroke | | 190.23B |
|
| Z82.4 - Family history of ischemic heart disease and other diseases of the circulatory system | | 190.23B |
|
| Z82.49 - Family history of ischemic heart disease and other diseases of the circulatory system | | 190.23B |
|
| Z82.71 - Family history of polycystic kidney | | 190.23B |
|
| Z83.0 - Family history of human immunodeficiency virus [HIV] disease | | 190.23B |
|
| Z83.3 - Family history of diabetes mellitus | | 190.23B |
|
| Z83.42 - Family history of familial hypercholesterolemia | | 190.23B |
|
| Z83.43 - Family history of other disorder of lipoprotein metabolism and other lipidemias | | 190.23B |
|
| Z83.430 - Family history of elevated lipoprotein(a) | | 190.23B |
|
| Z83.49 - Family history of other endocrine, nutritional and metabolic diseases | | 190.23B |
|
| Z84 - Family history of other conditions | | 190.23B |
|
| Z84.81 - Family history of carrier of genetic disease | | 190.23B |
|
| Z85.85 - Personal history of malignant neoplasm of endocrine glands | | 190.23B |
|
| Z85.9 - Personal history of malignant neoplasm, unspecified | | 190.23B |
|
| Z86.69 - Personal history of other diseases of the nervous system and sense organs | | 190.23B |
|
| Z86.7 - Personal history of diseases of the circulatory system | | 190.23B |
|
| Z86.73 - Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits | | 190.23B |
|
| Z86.79 - Personal history of other diseases of the circulatory system | | 190.23B |
|
| Z87.798 - Personal history of other (corrected) congenital malformations | | 190.23B |
|
| Z87.891 - Personal history of nicotine dependence | | 190.23B |
|
| Z92.23 - Personal history of estrogen therapy | | 190.23B |
|
| Z94.0 - Kidney transplant status | | 190.23B |
|
| Z94.1 - Heart transplant status | | 190.23B |
|
| Z94.3 - Heart and lungs transplant status | | 190.23B |
|
| Z94.4 - Liver transplant status | | 190.23B |
|
| Z94.89 - Other transplanted organ and tissue status | | 190.23B |
|
| Z94.9 - Transplanted organ and tissue status, unspecified | | 190.23B |
|
| Z98.6 - Angioplasty status | | 190.23B |
|
| Z98.61 - Coronary angioplasty status | | 190.23B |
|
| Z98.62 - Peripheral vascular angioplasty status | | 190.23B |
|